Skip to main content
Log in

Influence of Dalargin, a Peripheral Opiate Receptor Agonist, on Exercise Tolerance in Patients with Coronary and Peripheral Artery Atherosclerosis

  • Published:
Human Physiology Aims and scope Submit manuscript

Abstract

The study showed that chronic stimulation of peripheral μ- and δ-opiate receptors by a course of intravenous D-Ala2–Leu5-Arg6-enkephalin (dalargin) causes an antianginal effect in patients with ischemic heart disease (IHD) and increases tolerance to exercise in patients with atherosclerosis of coronary and peripheral arteries. Prolonged activation of peripheral μ- and δ-receptors causes a venodilator effect and decreases the tone of peripheral arteries in patients with IHD and atherosclerosis of lower extremities. After a course of dalargin, the chronotropic response to exercise strengthens in patients with IHD and the hypertensive response to threshold exercise weakens in patients with atherosclerosis of lower extremities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Hughes, J., Smith, T.W., Kosterlitz, H.W., et al., Identification of Two Related Pentapeptides from the Brain with Potent Opiate Agonist Activity, Nature, 1975, vol. 258, p. 577.

    Google Scholar 

  2. Pasternak, G.W., Simantov, R., and Snyder, S.H., Characterization of an Endogenous Morphine-like Factor (Enkephalin) in Mammalian Brain, Mol. Pharmacol., 1976, vol. 12, p. 504.

    Google Scholar 

  3. Bradbury, A.F., Smyth, D.G., Snerr, C.R., et al., C-Fragment of Lipoprotein Has a High Affinity for Brain Opiate Receptors, Nature, 1976, vol. 260, p. 793.

    Google Scholar 

  4. Cox, B.M., Goldstein, A., and Li, C.H., Opioid Activity of a Peptide, Beta-Endorphin (61-91), Derived from Beta-Lipotropin, Proc. Natl. Acad. Sci. USA, 1976, vol. 73, p. 1821.

    Google Scholar 

  5. Li, C.H. and Chung, D., Isolation and Structure of an Untriakontapeptide with Opiate Activity from Camel Pituitary Glands, Proc. Natl. Acad. Sci. USA, 1976, vol. 73, p. 1145.

    Google Scholar 

  6. Goldstein, A., Fischli, W., Lowney, L.I., et al., Porcine Pituitary Dynorphin: Complete Amino Acid Sequence of the Biologically Active Heptadecapeptide, Proc. Natl. Acad. Sci. USA, 1981, vol. 78, p. 7219.

    Google Scholar 

  7. Zadina, J.E., Hackler, L., Ge, L.-J., and Kastin, A.J., A Potent and Selective Endogenous Agonist for the μ-Opiate Receptor, Nature, 1997, vol. 386, p. 499.

    Google Scholar 

  8. Dhawan, B.N., Cesselin, F., Raghubir, R., et al., International Union of Pharmacology. XII. Classification of Opioid Receptors, Pharmacol. Rev., 1996, vol. 48, no. 4, p. 567.

    Google Scholar 

  9. Sander, G.E., Lowe, R.F., Given, M.B., and Giles, T.D., Interactions between Circulating Peptides and the Central Nervous System in Hemodynamic Regulation, Am. J. Cardiol. 1989, vol. 64, p. 44C.

    Google Scholar 

  10. Willette, R. and Sapru, H., Pulmonary Opiate Receptor Activation Evokes a Cardiorespiratory Reflex, Eur. J. Pharmacol., 1982, vol. 78, p. 61.

    Google Scholar 

  11. Giles, T.D., Sander, G.E., Rice, J.C., and Quiroz, A.C., Systemic Methionine-Enkephalin Evokes Cardiostimulatory Responses in the Human, Peptides, 1987, vol. 8, p. 609.

    Google Scholar 

  12. Korobov, N.V., Dalargine, an Opioid-like Peptide with Peripheral Effect, Farmakol. Toksikol., 1988, no. 4, p. 35.

    Google Scholar 

  13. Lishmanov, Yu.B. and Maslov, L.N., Opioidnye neiropeptidy, stress i adaptatsionnaya zashchita serdtsa (Opioid Neuropeptides, Stress, and Adaptive Protection of the Heart), Tomsk: Tomsk. Gos. Univ., 1994.

    Google Scholar 

  14. Pokrovskii, A.V., Klinicheskaya angiologiya (Clinical Angiology), Moscow: Meditsina, 1979.

    Google Scholar 

  15. Bruse, R.A., Exercise Testing of Patients with Coronary Heart Disease, Ann. Clin. Res., 1971, vol. 3, no. 4, p. 323.

    Google Scholar 

  16. Gorbachev, V.V., Ischemic Heart Disease, in Prakticheskaya kardiologiya (Practical Cardiology), Gorbachev, V.V., Ed., Minsk: Vysheishaya Shkola, 1997, vol. 1, p. 127.

    Google Scholar 

  17. Gasilin, V.V. and Sidorenko, B.A., Stenokardiya (Angina Pectoris), Moscow: Meditsina, 1987.

    Google Scholar 

  18. Pushkar', Yu.T., Bol'shov, V.M., and Elizarova, N.A., Determination of Cardiac Release by Tetrapolar Chest Rheography and Its Metrological Capacities, Kardiologiya, 1977, no. 7, p. 85.

    Google Scholar 

  19. Pushkar', Yu.T., Tsvetkova, A.A., and Kheimets, G.I., Automated Determination of Minute Volume by Rheography, Byull. VKNTs AMN SSSR, 1980, no. 1, p. 45.

    Google Scholar 

  20. Mukharlamov, N.M., Sazonova, L.N., and Pushkar', Yu.T., Study of Peripheral Circulation by Automated Occlusive Plethysmography, Ter. Arkhiv, 1981, no. 12, p. 3.

    Google Scholar 

  21. Polonskii, V.M., Yarygin, K.N., and Krivosheev, I.G., Application Site (Central vs. Peripheral) of Antiulcerous Effect of Dalargin, a Synthetic Analog of Endogenous Opioids, in Experimental Model of Cystaminic Duodenal Ulcers in Rats, Byull. Eksp. Biol. Med., 1987, no. 4, p. 433.

    Google Scholar 

  22. Gerts, A. and Millan, M., Participation of Opioids and Opiate Receptors in Antinoniciception at Various Levels of the Nervous System, Farmakol. Toksikol., 1989, vol. 52, no. 3, p. 5.

    Google Scholar 

  23. Champion, H.C. and Kadowitz, P.J., D-[Ala2]endomorphin 2 and endomorphin 2 Have Nitric Oxide-dependent Vasodilator Activity in Rats, Am. J. Physiol., 1998, vol. 274, p. H1690.

    Google Scholar 

  24. Metelitsa, V.I., Spravochnik po klinicheskoi farmakologii serdechno-sosudistykh lekarstvennykh sredstv (Directory in Clinical Pharmacology of Cardiovascular Medicines), Moscow: Medpraktika, 1996.

    Google Scholar 

  25. Lishmanov, Yu.B., Maslov, L.N., Tam, S.V., and Bogomaz, S.A., Opioid System and Resistance of the Heart to Injuries in Patients with Ischemia-Reperfusion, Ross. Fiziol. Zh., 2000, vol. 86, no. 2, p. 164.

    Google Scholar 

  26. Schultz, J.E.J., Hsu, A.K., Nagase, H., and Gross, G.J., TAN-67, a δ1-Opioid Receptor Agonist, Reduces Infarct Size via Activation of Gi/o Proteins and KATP Channels, Am. J. Physiol., 1998, vol. 274, p. H909.

    Google Scholar 

  27. Samarenko, M.B. and Karpov, Yu.A., First Experience of the Clinical Application of Dalargin, a Domestic Synthetic Peptide, in Patients with Ischemic Heart Disease, Byull. VKNTs AMN SSSR, 1983, no. 2, p. 96.

    Google Scholar 

  28. Kalenikova, E.I., Dmitrieva, O.F., Korobov, N.V., et al., Pharmacokinetics of Dalargin, Vopr. Med. Khim., 1988, no. 1, p. 75.

    Google Scholar 

  29. Zaitsev, S.V., Vinogradova, V.A., Sergeeva, M.G., et al., Radioimmune and Radioreceptor Study of Pharmacokinetics of Dalargin, an Analog of Enkephalins, Byull. Eksper. Biol. Med., 1986, no. 6, p. 702.

    Google Scholar 

  30. Goldstein, A., Nestor, J.J., Naidu, A., and Newman, S.R., “DAKLI”: a Multipurpose Ligand with High Affinity and Selectivity for dynorphin (Кopioid) Binding Sites, Proc. Natl. Acad. Sci. USA, 1988, vol. 85, p. 7375.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maslov, L.N., Fedorova, N.A., Dudko, V.A. et al. Influence of Dalargin, a Peripheral Opiate Receptor Agonist, on Exercise Tolerance in Patients with Coronary and Peripheral Artery Atherosclerosis. Human Physiology 28, 581–586 (2002). https://doi.org/10.1023/A:1020282919749

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020282919749

Keywords

Navigation